top of page

NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
45963-0765-52 | J9171 | INJECTION, DOCETAXEL, 1 MG | DOCETAXEL (SINGLE-USE VIAL,PF) 20 MG/1 ML | IV |
47335-0150-40 | J9045 | INJECTION, CARBOPLATIN, 50 MG | CARBOPLATIN (PF) 10 MG/ML | IV |
47335-0151-40 | J9045 | INJECTION, CARBOPLATIN, 50 MG | CARBOPLATIN (PF) 10 MG/ML | IV |
47335-0171-49 | J7682 | TOBRAMYCIN, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, UNIT DOSE FORM, ADMINISTERED THROUGH DME, PER 300 MILLIGRAMS | TOBRAMYCIN (4 AMPULES X 14 POUCHES) 300 MG/5 ML | IH |
47335-0171-49 | J7682 | TOBRAMYCIN, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, UNIT DOSE FORM, ADMINISTERED THROUGH DME, PER 300 MILLIGRAMS | TOBRAMYCIN (4 AMPULES X 14 POUCHES) 300 MG/5 ML | IH |
47335-0177-95 | J3245 | INJECTION, TILDRAKIZUMAB, 1 MG | ILUMYA (PF) 100 MG/1 ML | SC |
47335-0177-95 | J3490 | UNCLASSIFIED DRUGS | ILUMYA (PF) 100 MG/1 ML | SC |
47335-0235-83 | None | METHOTREXATE, 2.5 MG, ORAL | METHOTREXATE 2.5 MG | PO |
47335-0235-96 | None | METHOTREXATE, 2.5 MG, ORAL | METHOTREXATE 2.5 MG | PO |
47335-0284-40 | J9045 | INJECTION, CARBOPLATIN, 50 MG | CARBOPLATIN (PF) 10 MG/ML | IV |
47335-0300-40 | J9045 | INJECTION, CARBOPLATIN, 50 MG | CARBOPLATIN (PF) 10 MG/ML | IV |
47335-0323-40 | J9171 | INJECTION, DOCETAXEL, 1 MG | DOCETAXEL (USP,SDV) 20 MG/1 ML | IV |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page
